著者名,論文名,雑誌名,ISSN,出版者名,出版日付,巻,号,ページ,URL,URL(DOI)
Roy S. Herbst and Alan Sandler,Bevacizumab and Erlotinib: A Promising New Approach to the Treatment of Advanced NSCLC,The Oncologist,1083-7159,Oxford University Press (OUP),2008-11-01,13,11,1166-1176,https://cir.nii.ac.jp/crid/1361418518726982400,https://doi.org/10.1634/theoncologist.2008-0108